Two Human Immunodeficiency Virus Vaccinal Lipopeptides Follow Different Cross-Presentation Pathways in Human Dendritic Cells

An efficient vaccine against human immunodeficiency virus (HIV) must induce good cellular immune responses. To do this, it must be processed and presented by dendritic cells, which are required for primary T-lymphocyte stimulation. We have previously shown that a model lipopeptide containing a short...

Descrición completa

Detalles Bibliográficos

Publicado en:	J Virol
Principais autores:	Andrieu, Muriel, Desoutter, Jean-François, Loing, Estelle, Gaston, Jésintha, Hanau, Daniel, Guillet, Jean-Gérard, Hosmalin, Anne
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 2003
Assuntos:	Virus-Cell Interactions
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140847/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12502869/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.2.1564-1570.2003
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!